Critics of the universal hepatitis C screening argue that it’s wasteful to test pregnant women for a disease that can’t be immediately treated, but results of a small phase I clinical trial suggest otherwise: pregnancy could be an excellent time to diagnose and cure hepatitis C infection.
Health care entrepreneur Bobby Brooke Herrera, a New Mexico native who grew up just south of Las Cruces, may hold the key to testing millions of Americans to see if they are infected and spreading the coronavirus. His company, E25Bio, is currently pushing to get the Federal Drug Administration’s Emergency Use Authorization by September 1 to launch on the market. As of July 2020, the company has raised $12.92 million in funding from Venture Capital, National Institutes of Health, and the Bill and Melinda Gates Foundation. Herrera was named among Forbes 2019 '30 under 30' for healthcare entrepreneurs.
Researchers at the University of Chicago Medicine Comprehensive Cancer Center, working with colleagues in Europe, created a deep learning algorithm that can infer molecular alterations directly from routine histology images across multiple common tumor types. The findings were published July 27 in Nature Cancer.
As we observe World Head and Neck Cancer Day 2020 (July 27), nationally known expert Tom Thomas, MD, MPH, has set out to clear up misunderstandings about how one type of head and neck cancer is related to human papillomavirus (HPV), which has historically been thought of primarily as a cause of cervical cancer. Dr. Thomas is medical director, Head and Neck Reconstructive Surgery and Transoral Robotic Surgery, Leonard B. Kahn Head and Neck Cancer Institute at Atlantic Health System’s Morristown Medical Center and Carol G. Simon Cancer Center. He is one of the leaders of the Atlantic HPV Center.
A Ludwig Cancer Research study has identified a new instance in which the simultaneous mutation of two nonessential genes—neither of which is on its own vital to cell survival—can cause cancer cell death.
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified the process by which stem cells in the airways of the lungs switch between two distinct phases — creating more of themselves and producing mature airway cells — to regenerate lung tissue after an injury.
The Golseth Young Investigator Award, honoring AANEM Founding Member, Dr. James Golseth, is presented annually to a medical student or physician in the early stages of his/her career for original research in NM and EDX medicine.
Researchers at Ludwig Institute for Cancer Research and University of California San Diego School of Medicine report that inhibiting a key enzyme caused human cancer cells associated with two major types of breast and ovarian cancer to die and in mouse studies reduced tumor growth.
A team of developmental biologists at the Morgridge Institute for Research has discovered a means by which schistosomes, parasitic worms that infect more than 200 million people in tropical climates, are able to outfox the host’s immune system.
The American Society of Anesthesiologists (ASA) has received the prestigious “Accreditation with Commendation” designation from the Accreditation Council for Continuing Medical Education (ACCME) in recognition of ASA’s high quality continuing medical education (CME) program. Of the applicants eligible to apply for “commendation,” approximately 10% receive the designation.
Albert Einstein College of Medicine has received a $9.5 million, five-year grant from the National Institutes of Health (NIH) to support the Einstein-Mount Sinai Diabetes Research Center (ES-DRC). The multi-institutional center is a leader in basic, translational, clinical, and community-based research and training in type 1 and type 2 diabetes, obesity, and other metabolic disorders.
Researchers have identified a microRNA (miRNA) that could promote hair regeneration. This miRNA – miR-218-5p – plays an important role in regulating the pathway involved in follicle regeneration, and could be a candidate for future drug development.
Scientists have long been concerned that the common practice of medical journals accepting commercial payments from pharmaceutical companies may lead to pro-industry bias in published articles. According to new research at The University of Texas at Austin, scientists were right to be concerned, but they were focusing on the wrong type of payments.
In a new article published by PLOS ONE, researchers reviewed 128,781 articles published in 159 different medical journals for markers of pro-industry bias, evaluating whether accepting advertising revenue, fulfilling reprint contracts or being owned by a large multinational publishing firm made a journal more likely to publish articles favorable to industry. They found that articles published in journals that accept reprint fees are nearly three times more likely to be written by authors who receive industry payments.
“I was honestly surprised by the findings here,” said S. Scott Graham, lead author of the study and assistant professor of
Though same-day access to IUDs increases the likelihood a woman will get the reproductive health care she wants and decreases the chance she’ll become pregnant when she doesn’t plan to, most providers in Ohio don’t offer the service, a new study has found.
DALLAS – June 22, 2020 – For decades, high-density lipoprotein (HDL) cholesterol has been dubbed “good cholesterol” because of its role in moving fats and other cholesterol molecules out of artery walls. People with higher HDL cholesterol levels tend to have lower rates of cardiovascular disease, studies have shown.
Although additional policies are needed to relieve insulin’s financial burden, researchers find a national cost-sharing cap helps privately insured children and young adults with type 1 diabetes pay less out-of-pocket.
Physician anesthesiologists have been on the frontlines caring for COVID-19 patients throughout the country, but in New Hampshire physicians have innovated with a Tele-Intensive Care Unit (TeleICU) hub to collaborate with physicians in rural hospitals to ensure infected patients from across the state get critical care expertise at no expense while receiving care close to home.
As COVID-19 continues to spread around the country, the Johns Hopkins Bloomberg School of Public Health, with Bloomberg Philanthropies, today announced a free new online course to help public health officials implement strong contact tracing programs to break the chain of novel coronavirus transmission.
New research from Penn Medicine shows a low risk of stroke in patients hospitalized for COVID-19. Notably, the majority of afflicted patients had existing risk factors, such as high blood pressure and diabetes. These findings provide more clarity about the role COVID-19 plays in causing stroke in a diverse population of the United States.
AACC President-Elect Dr. David Grenache discusses what we know so far about the body’s immune response to COVID-19, and why the presence of antibodies to the novel coronavirus doesn’t yet tell us whether or not a person is immune.
To provide another layer of support for lung transplant recipients, the Keck Medicine of USC lung transplant team launched a two-year observational pilot study to monitor patients post-discharge using Bluetooth-enabled devices and computer tablets.
Further delaying your preventative cancer care may cause more harm than good. Expert from Rutgers Cancer Institute of New Jersey explains how most colorectal cancers can be prevented through regular screenings, and it is safe to get your screenings, even during these difficult times.
Ivan Piñón, MD, once thought his future would lead to the lab bench. But a long career practicing as an endocrinologist has led him to the UNM Comprehensive Cancer Center to serve as a crucial part of the effort to build a thyroid and parathyroid center of excellence.
Researchers at Nationwide Children’s Hospital analyzed 549,807 calls made to Poison Control Centers in the U.S. for suicide-related cases involving OTC analgesics from 2000-2018 and found that both the overall number and rate of these cases increased by 57% and 34%, respectively, during this period.
Existing limited evidence suggests that wearing face coverings to protect against COVID-19 does not lead to a false sense of security and is unlikely to increase the risk of infection through wearers foregoing other behaviours such as good hand hygiene, say researchers from the University of Cambridge and King’s College London.
A Nature study authored by a global team of scientists and led by Sumit Chanda, Ph.D., professor at Sanford Burnham Prebys Medical Discovery Institute, has identified 21 existing drugs that stop the replication of SARS-CoV-2, the virus that causes COVID-19.
access_time Embargo lifts in 2 days
Embargo will expire:
4-Aug-2020 2:00 PM EDT
Released to reporters: 24-Jul-2020 5:10 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 4-Aug-2020 2:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Researchers at The Ohio State University Wexner Medical Center and College of Medicine found that spinal cord injuries in mice cause an acquired bone marrow failure syndrome that may contribute to chronic immune dysfunction.
About 30% of stroke patients develop dementia, yet researchers understand very little about why. UChicago Medicine joins a NIH-led national network of institutions working to better understand the risk factors that lead to vascular cognitive impairment and dementia (VCID), early stroke recovery and approaches to prevention.
Cardiologist and heart failure expert Sean Pinney, MD, has been named co-director of the Heart & Vascular Center and director of the Advanced Heart Failure, Transplant and Mechanical Circulatory Support Program at the University of Chicago Medicine.
A new study, which involved participants eating pizza well after feeling 'full' in order to test what immediate effects this had on the body, finds that our metabolism is surprisingly good at coping with over-indulgence.
Today’s Food and Drug Administration (FDA) approval of the first CAR T-cell therapy for mantle cell lymphoma (MCL) represents a key advance for patients with relapsed or treatment-resistant forms of the disease, say Dana-Farber Cancer Institute investigators who helped conduct the decisive clinical trial of the therapy.
Research presented at ASM Microbe Online found that 43% of Staphylococcus bacteria found on exercise equipment in university gyms were ampicillin-resistant, with 73% of those isolates being resistant to multiple additional drugs. The late Xin Fan, Ph.D., and her student Chase A. Weikel of West Chester University (WCU) conducted the research in cooperation with WCU's John M. Pisciotta, Ph.D., associate professor of Biology.
Drug-carrying lipid nanoparticles were created that incorporate neurotransmitters to help them cross the blood-brain barrier in mice. The innovation could overcome many limitations encountered in delivering drugs into the central nervous system.
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a new computational algorithm that has, for the first time, identified a spectrum of mutations in the noncoding portion of the human genome across five major pediatric cancers. The study, which was published today in Science Advances, used the algorithm to analyze more than 500 pediatric cancer patients’ mutations and gene expression profiles to develop a comprehensive list of potentially cancer-causing mutations.
An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and non-human primates, researchers report on July 23rd in the journal Cell.
As the global response to the SARS-COV-2 virus that causes COVID-19 approaches 200 days, Baylor Scott & White Research Institute, the research and development arm of Baylor Scott & White Health, is accelerating its pace of bringing clinical trials online.
Baylor Scott & White Research Institute continues to mobilize staff and resources, including components needed to integrate critical patient-safety measures at every participating site within the Baylor Scott & White system for industry sponsored drug trials, investigator-initiated drug trials and research studies, and observational and data studies designed to help increase knowledge around case trends, viral epidemiology, and care best practices.
UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that causes COVID-19.